Literature DB >> 22328024

Assessment of bioburden on human and animal tissues: part 2--results of testing of human tissue and qualification of a composite sample for routine bioburden determination.

John B Kowalski1, Karen Merritt, David Gocke, Joel Osborne.   

Abstract

A quantitative method was developed and validated to assess bioburden on tissue from human donors and to compare bioburden determination results to swab culture results from the same donor. An initial study with allograft tissue from 101 donors showed a wide range of bioburden levels; values from no colony-forming units (CFU) detected to >28,000 CFU were observed. Tissues from donors that had swab cultures negative for objectionable microorganisms generally had lower bioburden than tissues from donors where objectionable microorganisms were recovered by swab culturing. In a follow-up study with 1,445 donors, a wide range of bioburden levels was again observed on tissues from donors that were swab culture negative for objectionable microorganisms. Tissues from 885 (61%) of these donors had no recoverable bioburden (<2 CFU). Importantly, tissues from 560 (39%) of the donors had recoverable bioburden which ranged from 1 to >24,000 CFU. Identification of bioburden isolates showed a diversity of genera and species. In compliance with the recent revision of the American Association of Tissue Banks K2.210 Standard, the quantitative bioburden determination method was validated with a composite tissue sample that contains bone and soft tissue sections tested together in one extraction vessel. A recovery efficiency of 68% was validated and the composite sample was shown to be representative of all of the tissues recovered from a donor. The use of the composite sample in conjunction with the quantitative bioburden determination method will facilitate an accurate assessment of the numbers and types of contaminating microorganisms on allografts prior to disinfection/sterilization. This information will ensure that disinfection/sterilization processes are properly validated and the capability of the overall allograft process is understood on a donor by donor basis.

Entities:  

Mesh:

Year:  2012        PMID: 22328024     DOI: 10.1007/s10561-012-9296-2

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  3 in total

Review 1.  Experimental procedures for decontamination and microbiological testing in cardiovascular tissue banks.

Authors:  Paula Hansen Suss; Victoria Stadler Tasca Ribeiro; Juliette Cieslinski; Letícia Kraft; Felipe Francisco Tuon
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-06

2.  Stabilization and Sterilization of Pericardial Scaffolds by Ultraviolet and Low-Energy Electron Irradiation.

Authors:  Simona Walker; Jessy Schönfelder; Sems-Malte Tugtekin; Christiane Wetzel; Michael C Hacker; Michaela Schulz-Siegmund
Journal:  Tissue Eng Part C Methods       Date:  2018-12       Impact factor: 3.056

Review 3.  Radiation sterilization of tissue allografts: A review.

Authors:  Rita Singh; Durgeshwer Singh; Antaryami Singh
Journal:  World J Radiol       Date:  2016-04-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.